论文部分内容阅读
江苏红豆杉生物科技股份有限公司是红豆集团旗下的子公司之一,成立于2004年2月,致力于红豆杉资源研究、提取红豆杉中的紫杉醇制成抗癌药物。目前公司已建成红豆杉高科技产业园,培育一年生及以上的红豆杉3500万株,年育红豆杉苗600多万株,是国内最大的红豆杉实生苗繁育基地,也是全世界最大的红豆杉实生苗栽培基地之一,形成了规模化种植、抗癌原料紫杉醇提炼、盆栽及苗木外销、观光康复的庞大生态健康产业链,为
Jiangsu Taxus Biotechnology Co., Ltd. is one of the subsidiaries of Hongdou Group. Founded in February 2004, Jiangsu Taxus Biotechnology Co., Ltd. is devoted to the study of Taxus resources and extracts paclitaxel from Taxus to make anticancer drugs. At present, the company has built a yew high-tech industrial park, cultivating more than 35 million yew trees of annual and above and more than 6 million yew sprouts annually. It is the largest seedling breeding base of yew and the largest yew tree in the world Seedling cultivation base, formed a large-scale planting, anti-cancer raw materials paclitaxel extraction, potted plants and seedlings for export, sightseeing rehabilitation of the huge ecological health industry chain, as